Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

BACKGROUND: A serogroup A meningococcal polysaccharide–tetanus toxoid conjugate vaccine (PsA–TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daugla, DM, Gami, JP, Gamougam, K, Naibei, N, Mbainadji, L, Narbé, M, Toralta, J, Kodbesse, B, Ngadoua, C, Coldiron, ME, Fermon, F, Page, A-L, Djingarey, MH, Hugonnet, S, Harrison, OB, Rebbetts, LS, Tekletsion, Y, Watkins, ER, Hill, D, Caugant, DA, Chandramohan, D, Hassan-King, M, Manigart, O, Nascimento, M, Woukeu, A, Trotter, C, Stuart, JM, Maiden, MCJ, Greenwood, BM
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898950/
https://ncbi.nlm.nih.gov/pubmed/24035220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(13)61612-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados